• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BISTRO 试验中的中心层面液体管理实践及其与非少尿血液透析患者液体状态和血压缺乏关联。

Centre-level fluid management practices in the BISTRO trial and their lack of association with participant fluid status and blood pressure in non-anuric haemodialysis patients.

机构信息

School of Medicine, Faculty of Medicine and Health Sciences, David Weatherall Building, Keele University, Keele, Staffordshire, ST5 5BG, UK.

NIHR Devices for Dignity, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

出版信息

BMC Nephrol. 2024 Nov 6;25(1):398. doi: 10.1186/s12882-024-03837-y.

DOI:10.1186/s12882-024-03837-y
PMID:39506729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11542461/
Abstract

INTRODUCTION

Fluid assessment and management is a key aspect of good dialysis care and is affected by patient-level characteristics and potentially centre-level practices. In this secondary analysis of the BISTRO trial we wished to establish whether centre-level practices with the potential to affect fluid status were stable over the course of the trial and explore if they had any residual associations with participant's fluid status.

METHODS

Two surveys (S) of fluid management practices were conducted in 32 participating centres during the trial, (S1: 2017-18 and S2: 2021-22). Domains interrogated included: dialysate sodium concentration, (D-[Na]), fluid and salt intake, residual kidney function, use of diuretics, incremental start, approaches to fluid assessment, management and dialysate temperature, (D-C). Associations of these practices with the closeness of the participant's post-dialysis target weight to their normally hydrated weight, pre- and post-dialysis systolic (SBP) and diastolic blood pressure, (DBP), were analysed using intra-class correlations and multilevel modelling with adjustment for visit, age, sex and comorbidity burden.

RESULTS

Variations in centre practices were reported but did not change during the trial, apart from some relaxation in salt and fluid restriction in S2. For our measures of fluid status, measured 2501 times in 439 non-anuric incident haemodialysis patients, centre-level intraclass correlations were extremely low, whereas patient-level correlations ranged between 0.12 and 0.47, strongest for pre- and post-dialysis-SBP, less so for post-dialysis-DBP. Multi-level analysis found no associations between D-[Na], or assessment methods of fluid status. In S2, one centre, routinely using a D-C of 35°C had more divergence between the target and normally hydrated weight, but this was not observed in S1, and no other associations were found.

CONCLUSIONS

Centre-level fluid management practices were stable over the course of the BISTRO trial, and in contrast to patient-level factors, no centre-level associations were detected with fluid status or blood pressure. This may be because the trial imposed a standardised approach to fluid assessment in all trial participants who at least initially had residual kidney function, potentially over-riding the effects of other centre practices. Survey responses revealed substantial scope for developing and evaluating standardised protocols to optimise fluid management.

摘要

简介

液体评估和管理是透析护理的关键方面,受到患者个体特征和潜在中心实践的影响。在 BISTRO 试验的这项二次分析中,我们希望确定在试验过程中是否有影响液体状态的中心实践,并探讨它们是否与参与者的液体状态有任何残留关联。

方法

在试验期间,32 个参与中心进行了两次液体管理实践调查(S1:2017-18 年和 S2:2021-22 年)。调查的领域包括:透析液钠浓度(D-[Na])、液体和盐摄入量、残余肾功能、利尿剂的使用、增量开始、液体评估、管理和透析液温度(D-C)的方法。使用组内相关系数和多水平模型,调整就诊、年龄、性别和合并症负担,分析这些实践与参与者透析后目标体重与正常水化体重的接近程度、透析前和透析后收缩压(SBP)和舒张压(DBP)之间的关联。

结果

报告了中心实践的差异,但在试验期间没有改变,除了在 S2 中盐和液体限制有所放松。对于我们的液体状态测量,在 439 名非无尿性起始血液透析患者中进行了 2501 次测量,中心水平的组内相关系数极低,而患者水平的相关系数在 0.12 到 0.47 之间,最强的是透析前和透析后 SBP,透析后 DBP 较弱。多水平分析发现 D-[Na]或液体状态评估方法之间没有关联。在 S2 中,一个常规使用 35°C 透析液温度的中心,目标体重与正常水化体重之间的差异更大,但在 S1 中没有观察到这种情况,也没有发现其他关联。

结论

在 BISTRO 试验过程中,中心水平的液体管理实践保持稳定,与患者个体因素相反,没有发现中心水平与液体状态或血压之间的关联。这可能是因为试验对所有试验参与者采用了标准化的液体评估方法,这些参与者至少最初具有残余肾功能,可能会超过其他中心实践的影响。调查结果显示,有很大的空间来制定和评估标准化协议,以优化液体管理。

相似文献

1
Centre-level fluid management practices in the BISTRO trial and their lack of association with participant fluid status and blood pressure in non-anuric haemodialysis patients.BISTRO 试验中的中心层面液体管理实践及其与非少尿血液透析患者液体状态和血压缺乏关联。
BMC Nephrol. 2024 Nov 6;25(1):398. doi: 10.1186/s12882-024-03837-y.
2
Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients.BISTRO的原理与设计:一项随机对照试验,旨在确定生物电阻抗光谱法指导的液体管理能否维持初发血液透析患者的残余肾功能。
BMC Nephrol. 2017 Apr 26;18(1):138. doi: 10.1186/s12882-017-0554-1.
3
Cost-effectiveness of bioimpedance-guided fluid management in patients undergoing haemodialysis: the BISTRO RCT.血液透析患者生物阻抗引导下的液体管理的成本效益:BISTRO随机对照试验
Health Technol Assess. 2024 Sep 25:1-45. doi: 10.3310/JYPR4287.
4
Association between dialysate sodium concentration and interdialytic weight gain in patients undergoing twice weekly haemodialysis.在每周接受两次血液透析的患者中,透析液钠浓度与透析间期体重增加之间的关系。
BMC Nephrol. 2021 Jun 17;22(1):225. doi: 10.1186/s12882-021-02401-2.
5
The Effect of Dialysate Temperature on Dialysis Adequacy and Hemodynamic Stability: An Experimental Study with Crossover Design.透析液温度对透析充分性和血液动力学稳定性的影响:采用交叉设计的实验研究。
G Ital Nefrol. 2024 Aug 26;41(4):2024-vol4. doi: 10.69097/41-04-2024-12.
6
Public and patient involvement (PPI) in the design, execution and dissemination of a trial: the BISTRO trial.公众和患者参与(PPI)在一项试验的设计、实施和传播中的应用:BISTRO试验
Health Technol Assess. 2025 Jan 29:1-18. doi: 10.3310/DOTR5903.
7
Residual renal function and volume control in peritoneal dialysis patients.腹膜透析患者的残余肾功能与容量控制
Nephron Clin Pract. 2006;104(1):c47-54. doi: 10.1159/000093670. Epub 2006 May 1.
8
Low dialysate sodium levels for chronic haemodialysis.慢性血液透析中低透析液钠水平。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD011204. doi: 10.1002/14651858.CD011204.pub3.
9
Low dialysate sodium levels for chronic haemodialysis.慢性血液透析的低透析液钠水平
Cochrane Database Syst Rev. 2019 Jan 16;1(1):CD011204. doi: 10.1002/14651858.CD011204.pub2.
10
Pre-dialysis fluid status, pre-dialysis systolic blood pressure and outcome in prevalent haemodialysis patients: results of an international cohort study on behalf of the MONDO initiative.透析前液体状态、透析前收缩压与现患血液透析患者预后的关系:一项代表 MONDO 倡议的国际队列研究结果。
Nephrol Dial Transplant. 2018 Nov 1;33(11):2027-2034. doi: 10.1093/ndt/gfy095.

引用本文的文献

1
BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trial.生物电阻抗光谱法维持肾输出量:BISTRO随机对照试验
Health Technol Assess. 2025 Jul;29(32):1-23. doi: 10.3310/RHON2378.

本文引用的文献

1
Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial.生物阻抗谱分析联合液体管理方案在一项随机对照试验中并未改善新进入血液透析患者的残余肾功能保留。
Kidney Int. 2023 Sep;104(3):587-598. doi: 10.1016/j.kint.2023.05.016. Epub 2023 May 30.
2
Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial.接受维持性血液透析患者的个性化冷却透析液(MyTEMP):一项实用、集群随机试验。
Lancet. 2022 Nov 12;400(10364):1693-1703. doi: 10.1016/S0140-6736(22)01805-0. Epub 2022 Nov 4.
3
The Elusive Promise of Bioimpedance in Fluid Management of Patients Undergoing Dialysis.
生物阻抗在透析患者液体管理中难以捉摸的前景。
Clin J Am Soc Nephrol. 2020 May 7;15(5):597-599. doi: 10.2215/CJN.01770220.
4
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.透析中的血压与容量管理:来自改善全球肾脏病预后(KDIGO)争议会议的结论
Kidney Int. 2020 May;97(5):861-876. doi: 10.1016/j.kint.2020.01.046. Epub 2020 Mar 8.
5
Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled Trial.个性化透析液温度(MyTEMP)的主要结局:一项基于注册登记、实用性、整群随机对照试验的原理与设计
Can J Kidney Health Dis. 2020 Feb 5;7:2054358119887988. doi: 10.1177/2054358119887988. eCollection 2020.
6
Associations between Hemodialysis Facility Practices to Manage Fluid Volume and Intradialytic Hypotension and Patient Outcomes.血液透析中心管理液体量和透析中低血压的实践与患者结局的关联。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):385-393. doi: 10.2215/CJN.08240718. Epub 2019 Feb 5.
7
Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients.BISTRO的原理与设计:一项随机对照试验,旨在确定生物电阻抗光谱法指导的液体管理能否维持初发血液透析患者的残余肾功能。
BMC Nephrol. 2017 Apr 26;18(1):138. doi: 10.1186/s12882-017-0554-1.
8
Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality.血液透析后体重高于和低于目标体重与全因死亡率和心血管死亡率的关联。
Clin J Am Soc Nephrol. 2015 May 7;10(5):808-16. doi: 10.2215/CJN.10201014. Epub 2015 Apr 10.
9
Blood pressure and mortality among hemodialysis patients.血液透析患者的血压与死亡率。
Hypertension. 2010 Mar;55(3):762-8. doi: 10.1161/HYPERTENSIONAHA.109.144899. Epub 2010 Jan 18.
10
Comparison of the Charlson Comorbidity Index and the Davies score as a predictor of outcomes in PD patients.比较Charlson合并症指数和戴维斯评分作为帕金森病患者预后预测指标的情况。
Perit Dial Int. 2003 Nov-Dec;23(6):568-73.